Position
Squarepoint Ops LLC in Cogent Biosciences, Inc.
Back to the book · All holders of COGT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $463.3K$35.52 → $38.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 156K | $5.54M | — | — | — | 0.0% |
| Q1 2026 | 226.3K | $8.71M | $38.49 | $463.3K | $2.7M | 0.0% |